DEVELOPMENT OF A NEGAMYCIN ANALOGUE TARGETING THE TRANSLATIONAL MACHINERY IN GRAM-NEGATIVE DRUG-RESISTANT PATHOGENS FOR THE TREATMENT OF INFECTIONS

Appili Therapeutics Inc

Investigators